NOTE TO THE FILE
Sent to TICRS as Serial Number: 88036772SERIAL NUMBER: 88036776
DATE: 11/08/2018
NAME: kmoninghoff
NOTE:
Searched:
Lexis/Nexis
OneLook
Wikipedia
Acronym Finder Protest evidence reviewed
Other:Checked:
Geographic significance
Surname
Translation
ID with ID/CLASS mailboxChecked list of approved Canadian attorneys and agents
Discussed file with
Attorney/Applicant via:
phone X Sent email to
email AttorneyRequested Law Library search Issued Examiner’s Amendment
for: and entered changes in TRADEUPSPRINT DO NOT PRINT Added design code in TRADEUPS
Description of the mark
Translation statement Re-imaged standard character
drawing
Negative translation statement
Consent of living individual Contacted TM MADRID ID/CLASS
about misclassified definite ID
Changed TRADEUPS to:X OTHER:
From: Moninghoff, Kim
Sent: Thursday, November 01, 2018 11:23 AM
To: 'mtepper@teiplaw.com' <mtepper@teiplaw.com>
Cc: 'tmorris@teiplaw.com' <tmorris@teiplaw.com>
Subject: Trademark Application #88036772 UMEZIRIS and three others
Mr. Tepper,
I’ve been assigned to review the four trademark applications you filed for this applicant:
No. 88036772 UMEZIRIS
No. 88036779 UMEBIRIS
No. 88036776 EVIMIRIS
No. 88036782 ADMIZIRIS
Before I can approve these applications for publication, the identifications need to be amended to specify the purpose of the goods. Based on the applicant’s website, I recommend the following:
Pharmaceutical preparations for the treatment of hematology, nephrology, neurology, and metabolic disorders, in Class 5.
If you consent to this amendment or can provide an acceptable alternative, you can let me know by reply email and I will enter it by Examiner’s Amendment and approve the marks for publication. If you have any questions, please let me know.
If I don’t hear back from you by the end of the day Wednesday (11/7), I will send you formal Office actions with this requirement. Thank you.
Kim Teresa Moninghoff
Trademark Examining Attorney
Law Office 113
Phone: 571-272-4738
Fax: 571-273-4738
All informal e-mail communications relevant to this application will be placed in the official application record.